ArticleBioactive materials2026
Novel multifunctional composite cryogel with high-performance and rapid fat-lowering efficacy via the synergy of fat digestion blockage and synthesis inhibition.
Article in Bioactive materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Nanomaterial-driven modulation of lipid metabolism: Novel strategies toward precision obesity treatment.Bioactive materials · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Excessive dietary fat intake poses considerable health risks. Developing biomaterials with fat adsorption and digestion intervention properties may satisfy consumer preferences for fat taste while enhancing anti-obesity efficacy. However, this strategy has remained largely unrealized. Cryogels, known for exceptional wettability and porous structure, are not employed as fat-blocking biomaterials with dual functionality. Herein, a novel curcumin (Cur)-releasing hydrophobic oral composite cryogel with excellent fat ingestion inhibition was fabricated using cellulose nanofiber (CNF) and carrageenan (Car). By optimizing the preparation process, the microstructure, porosity, and adsorption properties were analyzed to improve performance and functionality. Subsequently, the lipophilic performance and fat-lowering effect of the cryogel were further investigated through simulated gastrointestinal digestion and high-fat diet models. The proposed oral cryogels, with 91.10-98.70 % porosity and 145° hydrophobic angle, displayed favorable porous structure and fat/oil absorption capacity. Incorporation of Car-CNF-Cur cryogel reduced stimulated fat hydrolysis by 23.4 %. Additionally, supplementation with Car-CNF-Cur cryogels in high-fat diet significantly lowered body weight and fat synthetase expression in mice after short-term ingestion. This treatment also increased fecal fat content by 29.45 %, suppressed inflammation and lipopolysaccharide without toxicity, along with modulated gut microbiota composition, thereby interfering with fat digestion. Collectively, these findings highlight the potential of Car-CNF-Cur cryogels as a promising oral fat-lowering biomaterial for obesity management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.